Hormonal Contraceptive Market

Hormonal contraception is a type of contraceptive that utilizes hormones to prevent pregnancy. These contraceptives work by either preventing ovulation or stopping the release of eggs from the ovaries. There are several different types of hormonal contraception, each with its own benefits and drawbacks.

One common type of hormonal contraception is the pill. The pill works by preventing ovulation by inhibiting the production of progesterone. Another common type of hormonal contraception is the patch. The patch works by releasing a low dose of estrogen every day throughout the month, which prevents ovulation. Other types of hormonal contraception include the ring, shot, and vaginal ring.

There is no one-size-fits-all answer when it comes to contraception, as the choice of contraceptive method depends on a variety of factors. However, one thing that is universally true is that the hormonal contraceptive market is growing rapidly. This is due in part to the increasing number of women who are taking control over their reproductive health and choices.

The hormonal contraceptive market is expected to grow at a CAGR of around **% during the forecast period of 2018–2031. This growth can be attributed to various factors, such as increasing awareness about the benefits and risks associated with hormonal contraception, the increasing prevalence of obesity and diabetes, and the rising number of women entering the workforce.

Some of the key investors in this market are Bayer AG; Merck & Co., Inc.; Viatris; Gedeon Richter; and AbbVie.